(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 73.28% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.23%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.33%.
Cibus's revenue in 2025 is $4,751,000.On average, 3 Wall Street analysts forecast CBUS's revenue for 2025 to be $175,911,378, with the lowest CBUS revenue forecast at $159,200,485, and the highest CBUS revenue forecast at $186,364,283. On average, 3 Wall Street analysts forecast CBUS's revenue for 2026 to be $267,958,829, with the lowest CBUS revenue forecast at $215,934,999, and the highest CBUS revenue forecast at $357,599,362.
In 2027, CBUS is forecast to generate $996,980,143 in revenue, with the lowest revenue forecast at $330,091,718 and the highest revenue forecast at $1,663,868,568.